Fernbush

Fernbush (Chamaebatiaria millefolium): A Comprehensive Reference

1. Identity, Taxonomy, and Botanical Description

1.1 Scientific Classification

Fernbush belongs to Chamaebatiaria, a monotypic genus of aromatic shrub in the rose family (Rosaceae), containing the single species Chamaebatiaria millefolium, which is known by the common names fern bush and desert sweet. Within the family Rosaceae, the genus Chamaebatiaria is placed in the subfamily Amygdaloideae and the tribe Sorbarieae. The formal botanical authority for the species is Chamaebatiaria millefolium (Torr.) Maxim., first described by John Torrey and given its current placement by Carl Johann Maximowicz.

Fernbush is what is known as a monotype: it is the only representative of a genus containing only one species. Its genus name comes from its physical resemblance to the mountain miseries of genus Chamaebatia, which are not closely related. This shrub is the closest relative of Spiraeanthus.

1.2 Etymology

The name Chamaebatiaria millefolium reflects its botanical lineage. The genus name "Chamaebatiaria" derives from the Greek words "chamae," meaning "low," and "batus," meaning "bush," while "millefolium" translates to "thousand leaves," a nod to the plant's finely dissected foliage, which resembles that of a fern.

1.3 Common Names

Common names for Chamaebatiaria millefolium include fernbush, desert fernbush, desert sweet, and tansybush. When the plant is blooming, some people refer to it as a "summer lilac."

1.4 Morphological Description

This is a hairy, sticky plant covered in fernlike foliage made up of fronds of small leaflets. At the ends of the erect branches of this spreading bush are inflorescences of white roselike flowers. The leaves are alternate, evergreen in the south and deciduous in the north, fragrant, and very finely bipinnately compound, appearing fern-like, light green above and pale-pubescent below, sticky, to 3½ inches long, with individual leaflets that are tiny, with lobed or wavy margins.

Stems display reddish-brown bark that peels with age; the leaves are sticky and fern-like. Evergreen in mild climates, fernbush drops its leaves in cooler areas, revealing beautiful smooth cinnamon bark.

Northern ecotypes (Idaho, Oregon) of this species are small-statured (to 4 feet), with bright green leaves, and exhibit late spring bloom. Southern ecotypes (southern Utah, Arizona) are often larger (up to 10 feet tall), have gray leaves, and exhibit late summer bloom. It is a densely branched, aromatic shrub boasting a profusion of small, showy, creamy-white flowers from mid-summer to fall. The flowers give way to ornamental seed heads that ripen to bronze.

1.5 Native Range and Habitat

Fernbush is hardy to USDA Zone 4, with a native range east of the Cascade and Sierra Nevada Mountains from Deschutes County, Oregon, to southern California, and eastward across southern Oregon and Idaho, Nevada, Utah, and northern Arizona and New Mexico. This shrub is a resident of scrub, woodland, and forests in western North America. Fernbush primarily grows in the arid and semi-arid regions of the western United States, particularly in the foothills of the Sierra Nevada and along the eastern slopes of the Rocky Mountains, typically found in sandy or rocky soils.

Fernbush can survive in environments with less than 10 inches of annual rainfall. According to the USFS Fire Effects Information System, fernbush is browsed by wildlife, but not enough to be a significant ecological factor.

2. Traditional and Historical Use

2.1 Indigenous North American Ethnobotanical Uses

Historically, fernbush has held a valued place in traditional herbal medicine among indigenous peoples and early settlers. Its aromatic leaves and stems were commonly brewed into teas or made into poultices to address a variety of health concerns.

The most precisely documented ethnobotanical record comes from the BRIT Native American Ethnobotany Database. The Shoshoni use category recorded in that database is "Drug / Gastrointestinal Aid," with notes specifying that a decoction of fresh or dried leaves was taken for stomachaches or cramps. This record is corroborated by Colorado State University Extension documentation: according to the Native American Ethnobotany database, the Shoshoni tribe used the foliage as an analgesic for stomach aches or cramps, while the Navajo Ramah rolled its leaves inside corn husks to smoke for good luck in hunting.

The plant is native to the Great Basin region to the northwest, where it has been used medicinally by the Gosiute, Paiute, and Shoshoni. According to ethnobotanist Paul Vestal, the Navajo Ramah smoked the leaves in corn husks to prepare for a hunt and blew the smoke toward the place where they hoped to find deer.

Native American groups such as the Navajo, Shoshone, and Paiute are reported to have utilized fernbush as a remedy for digestive discomfort, fevers, and inflammation. The plant's astringent properties made it reportedly useful for wound cleansing and promoting skin health, while its soothing effects provided relief for respiratory issues such as coughs and colds. It must be noted, however, that these broader accounts draw on general ethnobotanical surveys and historical documentation rather than rigorous modern study design. The Shoshoni gastrointestinal use is the most precisely documented in a primary ethnobotanical database record.

2.2 Preparation Methods in Traditional Use

Based on the sources available, traditional preparations of fernbush involved the following documented forms:

• Decoction of leaves: A decoction of fresh or dried leaves was taken internally for stomachaches or cramps, as recorded in the Shoshoni ethnobotanical record.
• Smoking (ritual/ceremonial use): The Navajo Ramah rolled its leaves inside corn husks to smoke for good luck in hunting.
• Poultices: Leaves and stems were made into poultices to address a variety of external health concerns.

No dosage amounts or preparation ratios for traditional uses are recorded in the available authoritative sources.

3. Botanical Chemistry: Key Constituents and Active Compounds

3.1 Essential Oil Composition

The most significant phytochemical characterization of Chamaebatiaria millefolium was published in a peer-reviewed study in the journal Economic Botany by Tucker, Maciarello, and Henrickson (2003). The essential oil of Chamaebatiaria millefolium from California is dominated by 24.90 ± 4.46% camphor, 17.36 ± 4.23% borneol, 11.17 ± 4.26% camphene, and 10.95 ± 4.59% α-pinene.

These four compounds together account for approximately 65% of the essential oil by that analysis. All four belong to the monoterpene class of volatile organic compounds. Their individual chemical identities and known biological properties (established from research on other botanical sources) are described in the following sections.

3.2 Camphor

Camphor (C₁₀H₁₆O) is a white crystalline solid existing in enantiomeric R and S forms, and is a terpene derived from turpentine. It is the dominant volatile constituent of fernbush essential oil at approximately 25%. Camphor has been documented to have antipyretic, antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, and antitumor activities, and to serve as a skin penetration enhancer. Camphor has been widely used to treat minor conditions like pain, irritation, inflammation, congestion, and infections. These pharmacological characterizations refer to camphor as an isolated compound studied in the context of various botanical sources, not to fernbush extracts themselves.

3.3 Borneol

Borneol is the second most abundant constituent identified in fernbush essential oil at approximately 17%. The volatile aromatic compounds borneol and camphor are believed to play a significant role in anti-inflammatory effects observed in plants where they occur as major constituents. Research on borneol-containing essential oils has shown that borneol-rich preparations disrupt the bacterial cell wall causing leakage of nucleic acids and proteins, and in LPS-induced RAW 264.7 macrophages, reduce the production of TNF-α, IL-1β, and IL-6 in a dose-dependent manner. These are in vitro findings from studies on other plant systems and are not specific to fernbush.

3.4 Camphene

Camphene is the third major constituent of fernbush essential oil at approximately 11%. Camphene (C₁₀H₁₆), also called 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane, is a volatile compound belonging to the terpenoid family, specifically to the group of monoterpene hydrocarbons. It is a secondary metabolite found in various aromatic and medicinal plants, especially Thymus, Origanum, and Salvia genera, and is considered one of the major components of their essential oils. Numerous in vitro and in vivo investigations have established biological properties of camphene including antibacterial, antifungal, anticancer, antioxidant, antiparasitic, antidiabetic, anti-inflammatory, and hypolipidemic activities. Camphene was also reported to exhibit anti-leishmanial, hepatoprotective, antiviral, and anti-acetylcholinesterase inhibitory activities. All of these findings derive from research on camphene as an isolated compound, not from studies of fernbush specifically.

3.5 α-Pinene

α-Pinene constitutes approximately 11% of fernbush essential oil. α- and β-pinene are well-known representatives of the monoterpenes group, found in many plants' essential oils. A wide range of pharmacological activities have been reported, including antibiotic resistance modulation, anticoagulant, antitumor, antimicrobial, antimalarial, antioxidant, anti-inflammatory, anti-leishmania, and analgesic effects.

A study published in PubMed demonstrated a specific mechanism of anti-inflammatory action: α-pinene exhibits anti-inflammatory activity through the suppression of mitogen-activated protein kinases (MAPKs) and the nuclear factor-kappa B (NF-κB) pathway in mouse peritoneal macrophages. Investigations showed that α-pinene significantly decreased the LPS-induced production of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and nitric oxide (NO), and inhibited inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expressions in LPS-stimulated macrophages. Additionally, the activations of MAPKs and NF-κB were attenuated by α-pinene treatment. These mechanistic findings are from preclinical (mouse) in vitro studies and have not been replicated in human clinical trials using fernbush preparations.

3.6 Other Phytochemical Classes

Beyond the essential oil, fernbush is noted to contain broader categories of phytochemicals. Fernbush is known to contain a range of phytochemicals, including flavonoids and tannins, which are associated with antioxidant and anti-inflammatory activities in other botanical species. However, no detailed quantitative phytochemical analysis of these non-volatile fractions of Chamaebatiaria millefolium was identified in the peer-reviewed literature at the time of writing.

A critical note from the 2003 Tucker et al. study published in Economic Botany is relevant to the supplement marketplace: no scientific literature exists to substantiate the medicinal claims for "Chamae Rose," and neither Chamaebatiaria multiflorium nor Chamaebatiaria nelleae exist in the scientific literature. This finding cautions that product marketing invoking variant species names or novel medicinal claims without scientific backing is not substantiated.

4. Scientific Evidence by Area of Use

4.1 Overview of the Evidence Base

It is critical to state at the outset that, as of the time of writing, no published human clinical trials, randomized controlled trials, or systematic reviews specifically evaluating Chamaebatiaria millefolium as a dietary supplement, herbal medicine, or health intervention were identified in the peer-reviewed literature (PubMed/PMC, Cochrane, or equivalent databases). No pharmacopoeial monograph (WHO, ESCOP, Commission E, USP, or European Pharmacopoeia) covers this species. All available scientific evidence is therefore indirect: it concerns the well-characterized biological properties of the individual monoterpene constituents identified in fernbush essential oil, studied in isolation or in other botanical systems.

Ethnobotanical uses of fernbush have spurred interest in its potential as a functional ingredient in modern nutritional products. However, interest and established efficacy are not equivalent, and the gap between them for this plant is large.

4.2 Anti-Inflammatory Activity

Evidence type: In vitro and in vivo (animal) studies of constituent compounds only. No human clinical data for fernbush extracts.

The monoterpene profile of fernbush essential oil — dominated by camphor, borneol, camphene, and α-pinene — is consistent with a theoretical anti-inflammatory action, given that all four compounds have individually demonstrated relevant biological activities in preclinical research. The volatile aromatic compounds borneol and camphor are believed to play a significant role in anti-inflammatory effects. α-Pinene significantly decreased the LPS-induced production of IL-6, TNF-α, and nitric oxide, and inhibited iNOS and COX-2 expressions; additionally, the activations of MAPKs and NF-κB were attenuated by α-pinene treatment in mouse macrophage models. Numerous in vitro and in vivo investigations have also proven anti-inflammatory activity of camphene.

Whether these constituent-level findings translate to meaningful anti-inflammatory activity from whole fernbush preparations (tea, extract, or supplement) in human subjects has not been established. Evidence strength: preliminary, indirect, preclinical only.

4.3 Antimicrobial Activity

Evidence type: In vitro studies of constituent compounds only. No human clinical data for fernbush extracts.

The dominant constituents of fernbush essential oil — camphor, borneol, camphene, and α-pinene — each have demonstrated antimicrobial properties in in vitro research. Camphor has documented antibacterial and antifungal activities. Minimum inhibitory concentrations of borneol-rich preparations against Staphylococcus epidermidis were determined by broth microdilution at 0.5 mg/mL, with mechanistic studies revealing disruption of the bacterial cell wall, causing leakage of nucleic acids and proteins, and ultimately bacterial death. A wide range of pharmacological activities of α-pinene have been reported, including anticoagulant, anti-inflammatory, anti-leishmania, antimalarial, antimicrobial, antioxidant, antitumor, and analgesic effects.

For camphene, camphene showed antifungal potential against K. fragilis, R. rubra, and C. albicans in vitro, and camphene generally exerts antifungal action at the level of the membrane and membrane-embedded enzymes via changing the fatty acid composition of the cell membrane, resulting in inhibition of respiration and alteration of cell permeability.

Evidence strength: preliminary, indirect, in vitro only. No studies have tested fernbush preparations against specific pathogens, and no clinical data exist.

4.4 Antioxidant Activity

Evidence type: In vitro and animal studies of constituent compounds. No human clinical data for fernbush extracts.

Bioactive molecules including borneol have demonstrated antioxidant activity with potential to remove free radicals. Camphor and alpha-pinene have anti-inflammatory, antibacterial, anxiolytic, analgesic, immunomodulatory, antihyperlipidemic, and other pharmacological properties established in vitro or in vivo preclinical research. The polyphenolic classes (flavonoids and tannins) reported in fernbush as a species are also broadly associated with antioxidant function in the botanical literature, though quantitative data specific to Chamaebatiaria millefolium are lacking in the primary literature.

Evidence strength: very preliminary, indirect, extrapolated from constituent data.

4.5 Analgesic and Pain-Modulating Effects

Evidence type: In vitro / animal studies of constituent compounds; one established ethnobotanical record.

The Shoshoni gastrointestinal aid use — a decoction of fresh or dried leaves taken for stomachaches or cramps — is the most precisely documented analgesic/antispasmodic traditional use, recorded in the BRIT Native American Ethnobotany Database. At the constituent level, a wide range of pharmacological activities have been reported for α-pinene and β-pinene, including analgesic effects. Pinenes have been described as having anticoagulant, antitumor, antimalarial, antioxidant, anti-inflammatory, and analgesic properties.

Evidence strength: traditional use supported by one primary ethnobotanical database record; mechanistic plausibility provided by constituent-level preclinical data only. No human studies of fernbush for pain management exist.

4.6 Gastrointestinal Applications

Evidence type: Ethnobotanical record; no clinical data.

The primary and most reliably documented application of fernbush in any traditional healing system is gastrointestinal. The Shoshoni tribe's recorded use, as catalogued in the Native American Ethnobotany database, specifies a decoction of fresh or dried leaves taken for stomachaches or cramps. No controlled studies in human subjects or animal models testing fernbush preparations for gastrointestinal conditions have been identified in the scientific literature.

Evidence strength: ethnobotanical record only; no clinical or preclinical experimental evidence for the whole plant.

4.7 Respiratory Applications

Evidence type: Traditional/historical claims only; no clinical data for fernbush itself.

The plant's soothing effects reportedly provided relief for respiratory issues such as coughs and colds in traditional use contexts. Camphor, the dominant constituent, is well known as a topical counterirritant and expectorant ingredient (used in over-the-counter products such as vapor rubs in many pharmacopoeial contexts), though this is based on camphor as an isolated substance, not on fernbush preparations. Camphor has been widely used to treat minor conditions including congestion.

Evidence strength: traditional/anecdotal; no clinical evidence specifically for fernbush.

4.8 Wound, Skin, and Topical Applications

Evidence type: Historical reports; constituent-level preclinical data.

The plant's astringent properties reportedly made it useful for wound cleansing and promoting skin health. The tannins noted in the broader phytochemical literature as likely constituents of Rosaceae shrubs would be consistent with astringent activity. At the constituent level, borneol-rich extracts dose-dependently reduced the production of TNF-α, IL-1β, and IL-6 in macrophage models, which has relevance to wound-healing research conducted on other botanical systems. No studies of fernbush preparations for wound care or dermatological conditions in human subjects have been published.

Evidence strength: very preliminary; traditional use claim with no direct experimental substantiation.

5. Body Systems and Health Areas of Association

Based on documented traditional uses and the known pharmacology of constituent compounds, fernbush has been associated with the following body systems and health areas. These associations are not equivalents of proven efficacy.

• Gastrointestinal system: Documented Shoshoni use for stomachaches and cramps via leaf decoction.
• Immune and inflammatory response: Association is derived from the anti-inflammatory properties of its dominant monoterpene constituents (camphor, borneol, camphene, α-pinene), all documented in preclinical research on those isolated compounds.
• Respiratory system: Traditional use of the plant reportedly provided relief for respiratory issues such as coughs and colds.
• Skin and integument: Astringent properties reportedly made it useful for wound cleansing and promoting skin health.
• Pain signaling: The Shoshoni used the foliage as an analgesic for stomach aches or cramps.

6. Dosage Forms and Reported Preparations

No human clinical studies have established or evaluated specific dosages of fernbush preparations. No pharmacopoeial monograph defines a standardized dosage. The following forms have been documented in ethnobotanical or botanical reference sources:

• Leaf decoction (internal): A decoction of fresh or dried leaves taken for stomachaches or cramps is the single preparation form documented in the BRIT Native American Ethnobotany database. No quantity, concentration, or frequency is specified in the record.
• Leaf tea/infusion: Aromatic leaves and stems were commonly brewed into teas to address health concerns in traditional herbal practice contexts, though no quantitative parameters are recorded.
• Poultice (topical): Leaves and stems were made into poultices for external application.
• Smoked leaves (non-medicinal/ritual): The Navajo Ramah rolled leaves inside corn husks to smoke for ritual/hunting preparation purposes.
• Essential oil: The essential oil composition has been characterized in the peer-reviewed literature, but no therapeutic dosage forms or protocols involving fernbush essential oil have been clinically evaluated.

Commercial supplement products marketed as containing fernbush do exist, but the sources available for this article do not include peer-reviewed clinical evidence supporting any specific commercial dosage form or quantity. Product claims encountered in supplement marketing have not been substantiated by the scientific literature reviewed.

7. Safety Considerations and Potential Interactions

7.1 Absence of Formal Safety Data

No clinical safety studies, toxicological studies, or adverse event surveillance data specific to Chamaebatiaria millefolium preparations for human consumption were identified in the peer-reviewed literature or in government/institutional databases (NIH ODS, NCCIH, EMA, EFSA) at the time of writing. No LD50 or other formal toxicity parameters have been published for fernbush extracts or preparations.

7.2 Camphor Toxicity: A Critical Constituent-Level Concern

Camphor, the dominant constituent of fernbush essential oil at approximately 25%, has a well-characterized toxicological profile that warrants specific attention. Camphor has antipyretic, antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, and antitumor activities, and has been widely used to treat minor conditions like pain, irritation, inflammation, congestion, and infections — but camphor is also recognized as toxic in excess. Camphor can cause seizures and central nervous system toxicity when ingested in significant quantities; the FDA has historically limited the allowable concentration of camphor in over-the-counter topical products. Whether fernbush preparations (teas, decoctions, or extracts) deliver pharmacologically or toxicologically meaningful camphor doses has not been quantified in any published study.

7.3 Notes on Supplement Market Claims

No scientific literature exists to substantiate the medicinal claims for "Chamae Rose," and neither Chamaebatiaria multiflorium nor Chamaebatiaria nelleae exist in the scientific literature, as concluded by Tucker et al. (2003) in Economic Botany. This is a direct caution against supplement products marketed under these alternative names or species designations, as they have no recognized botanical standing.

7.4 Potential Drug Interactions

No drug interaction data specific to fernbush preparations exist in the published literature. At the constituent level, α-pinene has been noted in some pharmacological contexts for effects on platelet aggregation — a 2011 study showed that alpha-pinene derivatives isolated from Angelica sinensis inhibited platelet aggregation and exhibited weak antithrombin activity — which raises a theoretical concern for interaction with anticoagulant medications if relevant concentrations were achieved, though this has not been demonstrated for fernbush itself. These are extrapolations and should not be interpreted as established interactions for fernbush preparations.

7.5 Populations of Concern

No clinical data exist regarding the safety of fernbush in pregnancy, lactation, pediatric populations, or individuals with hepatic or renal impairment. The camphor content of the essential oil, and the tannin content typical of Rosaceae shrubs, would theoretically merit caution in these groups, but no direct evidence applies to this species.

8. Ecological and Commercial Context

Currently, fernbush is not considered threatened or endangered. However, as with many native plants, habitat destruction and climate change pose challenges. Beyond its visual appeal in landscaping, it is often used in erosion control projects and to restore disturbed lands, thanks to its deep root system. In midsummer, it is adorned with showy, white flowers that attract diverse pollinators.

Fernbush has attracted commercial interest as a dietary supplement ingredient in recent years, primarily as a component of herbal blends. However, this commercial interest has substantially outpaced the scientific evidence base. No standardized extract, quality benchmark, or validated analytical method for fernbush supplement standardization appears in the published scientific literature or in pharmacopoeial references.

9. Summary of Evidence Quality

The following table summarizes the state of evidence for each area of use:

• Gastrointestinal aid (stomach cramps): Ethnobotanical record (Shoshoni, BRIT database). No clinical evidence.
• Anti-inflammatory: Constituent-level in vitro and animal preclinical data only. No clinical evidence for the whole plant.
• Antimicrobial: Constituent-level in vitro data only. No clinical evidence for the whole plant.
• Antioxidant: Inferred from constituent pharmacology; no direct experimental data on fernbush preparations.
• Analgesic: Traditional use claim (Shoshoni analgesic use); no clinical evidence.
• Respiratory support: Historical/traditional claim only; no clinical evidence.
• Wound and skin care: Historical/traditional claim; constituent-level plausibility; no clinical evidence.

Overall, the evidence base for fernbush as a therapeutic or dietary supplement agent is at the earliest stage of scientific investigation. The plant has a genuine ethnobotanical history, particularly among Great Basin Indigenous peoples, and its essential oil contains well-studied bioactive monoterpenes whose individual pharmacology is documented in the preclinical literature. However, no human clinical trials have been conducted with any preparation of Chamaebatiaria millefolium, no pharmacopoeial monograph exists, and no regulatory body has formally assessed the efficacy or safety of fernbush for any health condition. Claims made beyond these factual boundaries are not supported by current scientific evidence.

References

• Tucker AO, Maciarello MJ, Henrickson J et al. "The Essential Oils of Chamaebatiaria millefolium, Chamaebatia australis, and Chamaebatia foliolosa (Rosaceae) and Comments on 'Chamaebatiaria Multiflorium' and 'Chamaebatiaria nelleae' as Medicinal Plants." Economic Botany 57:570–575 (2003). Springer Nature.
• BRIT Native American Ethnobotany Database — Chamaebatiaria millefolium (Shoshoni gastrointestinal use record). Botanical Research Institute of Texas.
• Colorado State University Extension. "Perennial Profile: Chamaebatiaria millefolium (Fernbush)." 2020.
• Kim DS, et al. "Alpha-Pinene Exhibits Anti-Inflammatory Activity Through the Suppression of MAPKs and the NF-κB Pathway in Mouse Peritoneal Macrophages." PubMed PMID 26119957 (2015).
• Salehi B, et al. "Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature." PMC6920849. Biomolecules (2019).
• Erman MB. "Recent studies on pinene and its biological and pharmacological activities." PMC8222632 (2021).
• Rouhani M, et al. "In Vitro and in Vivo Biological Investigations of Camphene and Its Mechanism Insights: A Review." Food Reviews International 39(4) (2021). Taylor & Francis.
• PMC. "The Antibacterial and Anti-Inflammatory Potential of Cinnamomum camphora chvar. Borneol Essential Oil In Vitro." PMC12196741 (2025).
• Fazmiya MJA, et al. "Current Insights on Bioactive Molecules, Antioxidant, Anti-Inflammatory, and Other Pharmacological Activities of Cinnamomum camphora Linn." PMC9568346. Oxidative Medicine and Cellular Longevity (2022).
• IJPS Journal. "Pharmacology and Application of Camphor." International Journal of Pharmaceutical Sciences.
• Wikipedia. "Chamaebatiaria." (botanical taxonomy and morphology reference).
• Wikispecies. "Chamaebatiaria millefolium." (taxonomy with reference to USDA GRIN).
• iNaturalist. "Genus Chamaebatiaria."
• Oregon State University. "Chamaebatiaria millefolium." Landscape Plants.
• Utah State University Center for Water-Efficient Landscaping. "Desert Fernbush in the Landscape."
• Nature Abhors a Garden. "Fernbush." (citing Moerman, Dan. Native American Ethnobotany, 1998; and Vestal, Paul ethnobotanical records).
• ScienceDirect Topics. "Alpha-Pinene — an overview."
• ResearchGate. Tucker et al. "The Essential Oils of Chamaebatiaria millefolium…" — Abstract and citation record.